These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 31527148)

  • 81. An exploratory study of the views of community pharmacy staff on the management of patients with undiagnosed skin problems.
    Tucker R; Stewart D
    Int J Pharm Pract; 2015 Dec; 23(6):390-8. PubMed ID: 25689029
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A randomized controlled study of practice facilitation to improve the provision of medication management services in Alberta community pharmacies.
    Houle SK; Charrois TL; Faruquee CF; Tsuyuki RT; Rosenthal MM
    Res Social Adm Pharm; 2017; 13(2):339-348. PubMed ID: 27017157
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Pharmacists' perspectives about their role in care of patients with diabetes observing Ramadan.
    Almansour HA; Chaar B; Saini B
    Res Social Adm Pharm; 2017; 13(1):109-122. PubMed ID: 27053428
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Strategies to facilitate the implementation of collaborative practice agreements in chain community pharmacies.
    Bacci JL; Coley KC; McGrath K; Abraham O; Adams AJ; McGivney MS
    J Am Pharm Assoc (2003); 2016; 56(3):257-265.e2. PubMed ID: 27053276
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Addressing primary nonadherence: A collaboration between a community pharmacy and a large pediatric clinic.
    Hackerson ML; Luder HR; Beck AF; Wedig JM; Heaton PC; Frede SM
    J Am Pharm Assoc (2003); 2018; 58(4S):S101-S108.e1. PubMed ID: 29730152
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Is the paradigm of community pharmacy practice expected to shift due to COVID-19?
    Nadeem MF; Samanta S; Mustafa F
    Res Social Adm Pharm; 2021 Jan; 17(1):2046-2048. PubMed ID: 32565052
    [No Abstract]   [Full Text] [Related]  

  • 87. The impact of COVID-19 on pharmacy transitions of care services.
    Herzik KA; Bethishou L
    Res Social Adm Pharm; 2021 Jan; 17(1):1908-1912. PubMed ID: 33162381
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The developing role of community pharmacists in facilitating care transitions: A systematic review.
    Kooyman CDA; Witry MJ
    J Am Pharm Assoc (2003); 2019; 59(2):265-274. PubMed ID: 30660452
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Community Pharmacists as Partners in Reducing Suicide Risk.
    Mospan CM; Gillette C; McKee J; Daniel SS
    J Am Board Fam Med; 2019; 32(6):763-767. PubMed ID: 31704742
    [No Abstract]   [Full Text] [Related]  

  • 90. Clinical pharmacists in primary care: a safe solution to the workforce crisis?
    Komwong D; Greenfield G; Zaman H; Majeed A; Hayhoe B
    J R Soc Med; 2018 Apr; 111(4):120-124. PubMed ID: 29480743
    [No Abstract]   [Full Text] [Related]  

  • 91. Self-medication in Poland: the pharmacist's advisory role in Warsaw.
    Piecuch A; Kozłowska-Wojciechowska M
    Int J Clin Pharm; 2013 Apr; 35(2):225-9. PubMed ID: 23225095
    [TBL] [Abstract][Full Text] [Related]  

  • 92. COVID-19 pandemic: The role of community pharmacists in chronic kidney disease management supportive care.
    Okoro RN
    Res Social Adm Pharm; 2021 Jan; 17(1):1925-1928. PubMed ID: 33317766
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Optimizing the public health platform.
    Maine LL
    Am J Pharm Educ; 2012 Nov; 76(9):165. PubMed ID: 23193329
    [No Abstract]   [Full Text] [Related]  

  • 94. I believe community pharmacists can contribute in the early screening and referral of patients at risk for metabolic syndrome. Do you?
    Rajanandh MG
    Diabetes Metab Syndr; 2020; 14(5):1291. PubMed ID: 32755823
    [No Abstract]   [Full Text] [Related]  

  • 95. Primary care clinical pharmacists and chronic disease medication adherence.
    Wormall S; Abbot S
    Br J Gen Pract; 2021 Nov; 71(712):496. PubMed ID: 34711560
    [No Abstract]   [Full Text] [Related]  

  • 96. Understanding the implementation, impact and sustainable use of an electronic pharmacy referral service at hospital discharge: A qualitative evaluation from a sociotechnical perspective.
    Jeffries M; Keers RN; Belither H; Sanders C; Gallacher K; Alqenae F; Ashcroft DM
    PLoS One; 2021; 16(12):e0261153. PubMed ID: 34936661
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Unlicensed "Special" Medicines: Understanding the Community Pharmacist Perspective.
    Wale A; Ireland M; Yemm R; Hiom S; Jones A; Spark JP; Francis M; May K; Allen L; Ridd S; Mantzourani E
    Integr Pharm Res Pract; 2020; 9():93-104. PubMed ID: 32884914
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Community pharmacist management of discharge medication summaries in primary care.
    Wilcock M; Bearman D
    Drug Ther Bull; 2019 Dec; 57(12):179-180. PubMed ID: 31527148
    [No Abstract]   [Full Text] [Related]  

  • 99. Integration of Community Pharmacists in Transition of Care (TOC) Services: Current Trends and Pharmacist Perceptions.
    Zeleznikar EA; Kroehl ME; Perica KM; Thompson AM; Trinkley KE
    J Pharm Pract; 2019 Feb; 32(1):28-35. PubMed ID: 29061080
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Experience with technology-supported transitions of care to improve medication use.
    Frail CK; Garza OW; Haas AL
    J Am Pharm Assoc (2003); 2016; 56(5):568-72. PubMed ID: 27521168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.